Why Should Companies Use Digital Endpoints Across Clinical Development?
XTalks
MAY 28, 2024
VivoSense , a pioneering company in the field of digital health technologies (DHTs) and digital endpoints for clinical trials, is aiming to enhance the efficiency and efficacy of clinical research. Clay is optimistic about the trajectory of DHTs in clinical trials.
Let's personalize your content